You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Exercise Disclosure
Townson Sharon · SEC Form 4 · Filed Jul 7, 2026
Exercise
Calculated transaction value
$0
Townson Sharon Chief Scientific Officer
GLUE
Transaction date
Jul 6, 2026
Public filing date
Jul 7, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$23.25
Jul 6, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 6,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-297558
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$176.69K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jul 6, 2026 | $36.84K |
| Monte Rosa Therapeutics, Inc. GLUE | Sale | Jul 6, 2026 | $130.2K |
| Monte Rosa Therapeutics, Inc. GLUE | Sale | Jul 6, 2026 | $9.65K |
| Monte Rosa Therapeutics, Inc. GLUE Current | Exercise | Jul 6, 2026 | $0 |